Inflection Biosciences is a developer of small molecule therapeutics for the treatment of cancer. Read more

4 Followers on Owler
4 Followers on Owler
4 Followers on Owler
4 Followers on Owler

Inflection Biosciences is a developer of small molecule therapeutics for the treatment of cancer. Read more

Darren Cunningham's photo - Co-Founder & CEO of Inflection Biosciences

Co-Founder & CEO

Darren Cunningham

CEO Approval Rating

82/100

Founded:

2012

Status:

PrivateIndependent Company

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

ELARA Pharmaceuticals is Inflection Biosciences's top competitor. ELARA Pharmaceuticals is a Private company that was founded in Heidelberg, Other in 2006. ELARA Pharmaceuticals operates in the industry. ELARA Pharmaceuticals has NaN fewer employees vs. Inflection Biosciences.

Opsona has been one of Inflection Biosciences's top competitors. Opsona is headquartered in Dublin, County Dublin, and was founded in 2004. Opsona is in the Biotechnology industry. Opsona generates 157% the revenue of Inflection Biosciences.

Protalex is perceived as one of Inflection Biosciences's biggest rivals. Protalex was founded in 1999 in Florham Park, New Jersey. Protalex competes in the Pharmaceuticals field. Protalex generates $4M less revenue than Inflection Biosciences.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Baliopharm a competitor of Inflection Biosciences?

Acquisitions

No recent acquisitions found related to Inflection Biosciences

Inflection Biosciences Funding History

$785.8K

Since Inflection Biosciences was founded in 2012, it has participated in 1 round of funding. In total Inflection Biosciences has raised $785.8K. Inflection Biosciences' funding round was on Mar 2015 for a total of $785.8K

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Mar 2015
$785.8K
-

Since Inflection Biosciences was founded in 2012, it has participated in 1 round of funding. In total Inflection Biosciences has raised $785.8K. Inflection Biosciences' funding round was on Mar 2015 for a total of $785.8K

Investments

No recent investments found related to Inflection Biosciences

Inflection Biosciences News

July 18, 2019THE IRISH TIMES

Irish company Inflection sells cancer drug to Singapore group

Irish drug development company Inflection Biosciences has signed a global deal for their leading canc... See more »
November 2, 2018THE IRISH TIMES

Irish drug company signs research deal with Texas university

Dublin drug development company Inflection Biosciences has signed a research deal with the University... See more »
November 1, 2018PharmiWeb

Inflection Biosciences Announces Research Collaboration with MD Anderson

Inflection Biosciences Announces Research Collaboration with MD AndersonInflection ...Inflection Bios... See more »
November 1, 2018PharmiWeb

Company Profile for Inflection Biosciences Ltd

Company Profile for Inflection Biosciences LtdInflection Biosciences Ltd, based in Dublin an...Inflec... See more »
August 10, 2018BioPortfolio

Inflection Biosciences Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23042018 Prices from USD $250

SummaryInflection Biosciences Ltd Inflection Biosciences is a drug development company that identifie... See more »
July 17, 20184-traders

Inflection Biosciences Announces Publication of Positive Data for Dual Mechanism Inhibitor Against Chronic Lymphocytic Leukaemia

(4-traders.com) Inflection Biosciences Ltd, a private company developing innovative therapeutics for ... See more »
April 16, 2018THE IRISH TIMES

Dublin company Inflection Biosciences signs research deal with Trinity College

Dublin drug development company Inflection Biosciences has signed a research deal with Trinity Colleg... See more »

Inflection Biosciences Press Releases

February 9, 2015PRESS RELEASE POINT

Multiple Myeloma Research Foundation and Inflection Biosciences Collaborate on a New Cancer Treatment

DUBLIN and NORWALK, Conn. - February 9, 2015- Inflection Biosciences Ltd., a private company developi... See more »

Social Media

Headquarters

Anglesea House, Carysfort Avenue Suite 15

Blackrock, County Dublin

353-1-4003615

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Inflection Biosciences is a developer of small molecule therapeutics for the treatment of cancer. Inflection Biosciences was founded in 2012. Inflection Biosciences' headquarters is located in Blackrock, County Dublin, IE . It has raised 785.8K in 1 r...

CEO

Inflection Biosciences's Co-Founder & CEO, Darren Cunningham, currently has an approval rating of 82%. Inflection Biosciences's primary competitors are ELARA Pharmaceuticals, Opsona & Protalex.

Website

inflectionbio.com

Frequently Asked Questions about Inflection Biosciences

  1. When was Inflection Biosciences founded?

    Inflection Biosciences was founded in 2012
  2. Who is Inflection Biosciences's CEO?

    Inflection Biosciences's CEO is Darren Cunningham
  3. How much revenue does Inflection Biosciences generate?

    Inflection Biosciences generates $4M in revenue
  4. How much funding does Inflection Biosciences have?

    Inflection Biosciences has historically raised $785.8K in funding
  1. Where is Inflection Biosciences's headquarters?

    Inflection Biosciences's headquarters is in Blackrock County Dublin, IE
  2. How many employees does Inflection Biosciences have?

    Inflection Biosciences has 30 employees
  3. What sector does Inflection Biosciences operate in?

    Inflection Biosciences is in Health Care Services
  4. Who are Inflection Biosciences's competitors?

    Inflection Biosciences's top competitors are ELARA Pharmaceuticals, Opsona, Protalex